Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,732 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A consensus document on definition and diagnostic criteria for orthorexia nervosa.
Donini LM, Barrada JR, Barthels F, Dunn TM, Babeau C, Brytek-Matera A, Cena H, Cerolini S, Cho HH, Coimbra M, Cuzzolaro M, Ferreira C, Galfano V, Grammatikopoulou MG, Hallit S, Håman L, Hay P, Jimbo M, Lasson C, Lindgren EC, McGregor R, Minnetti M, Mocini E, Obeid S, Oberle CD, Onieva-Zafra MD, Opitz MC, Parra-Fernández ML, Pietrowsky R, Plasonja N, Poggiogalle E, Rigó A, Rodgers RF, Roncero M, Saldaña C, Segura-Garcia C, Setnick J, Shin JY, Spitoni G, Strahler J, Stroebele-Benschop N, Todisco P, Vacca M, Valente M, Varga M, Zagaria A, Zickgraf HF, Reynolds RC, Lombardo C. Donini LM, et al. Among authors: valente m. Eat Weight Disord. 2022 Dec;27(8):3695-3711. doi: 10.1007/s40519-022-01512-5. Epub 2022 Nov 27. Eat Weight Disord. 2022. PMID: 36436144 Free PMC article.
The #orthorexia community on Instagram.
Valente M, Renckens S, Bunders-Aelen J, Syurina EV. Valente M, et al. Eat Weight Disord. 2022 Mar;27(2):473-482. doi: 10.1007/s40519-021-01157-w. Epub 2021 Apr 9. Eat Weight Disord. 2022. PMID: 33835422 Free PMC article.
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.
Coutts SB, Ankolekar S, Appireddy R, Arenillas JF, Assis Z, Bailey P, Barber PA, Bazan R, Buck BH, Butcher KS, Camden MC, Campbell B, Casaubon LK, Catanese L, Chatterjee K, Choi PMC, Clarke B, Dowlatshahi D, Ferrari J, Field TS, Ganesh A, Ghia D, Goyal M, Greisenegger S, Halse O, Horn M, Hunter G, Imoukhuede O, Kelly PJ, Kennedy J, Kenney C, Kleinig TJ, Krishnan K, Lima F, Mandzia JL, Marko M, Martins SO, Medvedev G, Menon BK, Mishra SM, Molina C, Moussaddy A, Muir KW, Parsons MW, Penn AMW, Pille A, Pontes-Neto OM, Roffe C, Serena J, Simister R, Singh N, Spratt N, Strbian D, Tham CH, Wiggam MI, Williams DJ, Willmot MR, Wu T, Yu AYX, Zachariah G, Zafar A, Zerna C, Hill MD; TEMPO-2 investigators. Coutts SB, et al. Lancet. 2024 May 16:S0140-6736(24)00921-8. doi: 10.1016/S0140-6736(24)00921-8. Online ahead of print. Lancet. 2024. PMID: 38768626
1,732 results